Search results
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Is Expected To Breakeven In The Near Future
Simply Wall St. via Yahoo Finance· 2 years agoParatek Pharmaceuticals, Inc. (NASDAQ:PRTK) is possibly approaching a major achievement in its...
Paratek Pharmaceuticals (NASDAQ:PRTK) investors are sitting on a loss of 83% if they invested five...
Simply Wall St. via Yahoo Finance· 1 year agoLong term investing is the way to go, but that doesn't mean you should hold every stock forever. It...
Could The Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Ownership Structure Tell Us Something Useful?
Simply Wall St. via Yahoo Finance· 2 years agoThe big shareholder groups in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) have power over the...
There's No Escaping Paratek Pharmaceuticals, Inc.'s (NASDAQ:PRTK) Muted Revenues Despite A 77% Share...
Simply Wall St. via Yahoo Finance· 1 year agoParatek Pharmaceuticals, Inc. (NASDAQ:PRTK) shareholders would be excited to see that the share...
Individual investors account for 39% of Paratek Pharmaceuticals, Inc.'s (NASDAQ:PRTK) ownership,...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), then you'll...
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoParatek Pharmaceuticals, Inc. (NASDAQ:PRTK) Q4 2022 Earnings Call Transcript March 16, 2023...
Paratek Pharmaceuticals Third Quarter 2022 Earnings: Misses Expectations
Simply Wall St. via Yahoo Finance· 2 years agoParatek Pharmaceuticals (NASDAQ:PRTK) Third Quarter 2022 ResultsKey Financial Results Revenue:...
7 Growth Stocks That Are Too Cheap to Ignore Right Now
InvestorPlace via Yahoo Finance· 1 year agoAlthough the equities sector recovered reasonably well from 2022’s harsh glare, rising headwinds...